Quota-Based Compensation Plans Outpace Ran... ( ZS Associates study shows quota-bas...)

Quota-Based Compensation Plans Outpace Ranking Plans

Date:9/30/2008

ZS Associates study shows quota-based plans most popular among makers of

pharmaceuticals/biotech, medical device and technology products

EVANSTON, Ill., Sept. 30 /PRNewswire/ -- The third annual Incentive Practices Research (IPR) study, conducted by global sales and marketing consulting firm ZS Associates (http://www.zsassociates.com), finds that an increasing number of companies - in pharmaceutical/biotech, medical products and high technology industries - are favoring quota-based compensation plans over ranking plans.

Ranking plans pay sales representatives and managers based on how they performed compared to their peers. These plans thrived during the late 1990s, especially in the pharmaceutical industry, as a way of managing compensation costs, but have steadily declined in popularity. ZS Associates' research has found that(1):

-- 73 percent of pharmaceutical/biotech companies surveyed use quota-based plans, while 20 percent use ranking plans

-- 85 percent of medical device companies surveyed use quota-based plans, while 21 percent use ranking plans

-- 89 percent of high tech companies surveyed use quota-based plans, while 26 percent use ranking plans

Stephen Redden, principal and leader of the Incentive Compensation Practice at ZS Associates, advises executives to deploy ranking plans cautiously, as they can promote unproductive competition between salespeople. "Knowing your sales compensation cost with certainty is an important objective, but using ranking plans to achieve this objective is not recommended," says Redden. "There are ways to structure quota-based plans - and model the costs - that can provide accurate compensation cost estimates without increasing the internal competition in the field."

Quota Fairness a Top Concern

The survey also indicates that quota-setting fairness is one of the most pressing concerns and cuts across al
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee
2. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
3. Coherent Announces Restatement Related to Stock-Based Compensation
4. Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
5. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
6. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
7. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
8. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
9. Favrille Announces Resolution of Debt Obligations and Plans for Maximizing Assets
10. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
11. NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO

Post Your Comments:

Quota-Based Compensation Plans Outpace Ran...( ZS Associates study shows quota-bas...)